Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value: $1.741B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TURNING POINT THERAPEUTICS I | 3,122,367 | $127M | 7.3% | $40.70 | — | COM | 90041T108 |
| — | MIRATI THERAPEUTICS INC | 1,100,000 | $113M | 6.5% | $21.20 | — | COM | 60468T105 |
| XBI | SPDR SERIES TRUST | 900,000 | $78.94M | 4.5% | — | — | Put | 78464A870 |
| — | REATA PHARMACEUTICALS INC | 806,150 | $76.06M | 4.4% | $55.54 | — | CL A | 75615P103 |
| APLS | APELLIS PHARMACEUTICALS INC | 2,966,108 | $75.16M | 4.3% | $15.50 | +31.2% | COM | 03753U106 |
| BBIO | BRIDGEBIO PHARMA INC | 2,780,885 | $75M | 4.3% | $27.26 | 0.0% | COM | 10806X102 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,550,000 | $67.88M | 3.9% | $41.49 | — | COM | G11196105 |
| STOK | STOKE THERAPEUTICS INC | 1,869,680 | $54.54M | 3.1% | $26.85 | 0.0% | COM | 86150R107 |
| — | AXONICS MODULATION TECH INC | 1,252,495 | $51.31M | 2.9% | $15.11 | — | COM | 05465P101 |
| QURE | UNIQURE NV | 600,000 | $46.89M | 2.7% | $63.72 | 0.0% | SHS | N90064101 |
| — | TRICIDA INC | 1,177,975 | $46.48M | 2.7% | $33.32 | — | COM | 89610F101 |
| ASND | ASCENDIS PHARMA A S | 400,000 | $46.06M | 2.6% | $76.66 | — | SPONSORED ADR | 04351P101 |
| — | PRINCIPIA BIOPHARMA INC | 1,361,898 | $45.2M | 2.6% | $29.22 | — | COM | 74257L108 |
| ANAB | ANAPTYSBIO INC | 700,000 | $39.49M | 2.3% | $39.24 | +83.5% | COM | 032724106 |
| — | QUOTIENT LTD | 3,800,000 | $35.53M | 2.0% | $8.95 | — | SHS | G73268107 |
| SRPT | SAREPTA THERAPEUTICS INC | 225,000 | $34.19M | 2.0% | $127.51 | -4.7% | COM | 803607100 |
| — | BLUEPRINT MEDICINES CORP | 350,000 | $33.02M | 1.9% | $69.23 | — | COM | 09627Y109 |
| CRSP | CRISPR THERAPEUTICS AG | 700,000 | $32.97M | 1.9% | $34.60 | +15.5% | NAMEN AKT | H17182108 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,074,595 | $31.12M | 1.8% | $16.57 | +5.3% | COM | 77313F106 |
| ASND | ASCENDIS PHARMA A S | 250,000 | $28.79M | 1.7% | $76.66 | — | Call | 04351P101 |
| — | ALLAKOS INC | 650,000 | $28.16M | 1.6% | $42.85 | — | COM | 01671P100 |
| KURA | KURA ONCOLOGY INC | 1,400,000 | $27.57M | 1.6% | $14.56 | +14.0% | COM | 50127T109 |
| — | MYOKARDIA INC | 500,000 | $25.07M | 1.4% | $17.38 | — | COM | 62857M105 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 550,000 | $24.09M | 1.4% | $41.49 | — | Call | G11196105 |
| — | Y-MABS THERAPEUTICS INC | 1,000,000 | $22.87M | 1.3% | $25.33 | — | COM | 984241109 |
| GLPG | GALAPAGOS NV | 175,000 | $22.58M | 1.3% | $116.55 | — | SPON ADR | 36315X101 |
| — | CHEMOCENTRYX INC | 2,365,280 | $22M | 1.3% | $13.89 | — | COM | 16383L106 |
| ARGX | ARGENX SE | 150,000 | $21.24M | 1.2% | $82.17 | — | SPONSORED ADR | 04016X101 |
| — | ARRAY BIOPHARMA INC | 450,000 | $20.85M | 1.2% | $6.75 | — | COM | 04269X105 |
| — | MIRATI THERAPEUTICS INC | 200,000 | $20.6M | 1.2% | $21.20 | — | Call | 60468T105 |
| TWST | TWIST BIOSCIENCE CORP | 706,064 | $20.48M | 1.2% | $22.16 | +19.4% | COM | 90184D100 |
| — | SAGE THERAPEUTICS INC | 100,000 | $18.31M | 1.1% | $161.07 | — | COM | 78667J108 |
| — | EIDOS THERAPEUTICS INC | 551,921 | $17.15M | 1.0% | $21.18 | — | COM | 28249H104 |
| — | CONSTELLATION PHARMCETICLS I | 1,271,685 | $15.62M | 0.9% | $6.73 | — | COM | 210373106 |
| VRTX | VERTEX PHARMACEUTICALS INC | 85,000 | $15.59M | 0.9% | $174.82 | 0.0% | COM | 92532F100 |
| — | NEXTCURE INC | 1,000,000 | $14.98M | 0.9% | $14.98 | — | COM | 65343E108 |
| — | AKERO THERAPEUTICS INC | 767,842 | $14.7M | 0.8% | $19.15 | — | COM | 00973Y108 |
| GOSS | GOSSAMER BIO INC | 643,129 | $14.27M | 0.8% | $20.85 | -8.3% | COM | 38341P102 |
| — | NEKTAR THERAPEUTICS | 400,000 | $14.23M | 0.8% | $69.99 | — | COM | 640268108 |
| — | X4 PHARMACEUTICALS INC | 890,387 | $13.36M | 0.8% | $15.68 | — | COM | 98420X103 |
| — | EIGER BIOPHARMACEUTICALS INC | 1,150,000 | $12.19M | 0.7% | $10.60 | — | COM | 28249U105 |
| INSP | INSPIRE MED SYS INC | 200,000 | $12.13M | 0.7% | $32.28 | +67.0% | COM | 457730109 |
| — | PHASEBIO PHARMACEUTICALS INC | 906,229 | $11.89M | 0.7% | $3.83 | — | COM | 717224109 |
| — | ARENA PHARMACEUTICALS INC | 200,000 | $11.73M | 0.7% | $42.46 | — | COM NEW | 040047607 |
| — | HEALTH SCIENCES ACQUSTN CORP | 1,080,000 | $11.45M | 0.7% | $10.60 | — | UNIT 04/01/2024 | 42227C201 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 700,000 | $11.27M | 0.6% | $31.47 | — | SPON ADS | 05280R100 |
| — | RA PHARMACEUTICALS INC | 350,000 | $10.53M | 0.6% | $18.20 | — | COM | 74933V108 |
| ZLAB | ZAI LAB LTD | 300,000 | $10.46M | 0.6% | $22.58 | — | ADR | 98887Q104 |
| — | ORCHARD THERAPEUTICS PLC | 730,325 | $10.22M | 0.6% | $16.35 | — | ADS | 68570P101 |
| — | AMARIN CORP PLC | 500,000 | $9.695M | 0.6% | $15.51 | — | SPONS ADR NEW | 023111206 |
| — | RUBIUS THERAPEUTICS INC | 600,000 | $9.438M | 0.5% | $21.38 | — | COM | 78116T103 |
| — | HARPOON THERAPEUTICS INC | 649,994 | $8.45M | 0.5% | $9.47 | — | COM | 41358P106 |
| — | ATRECA INC | 444,942 | $8.383M | 0.5% | $18.84 | — | CL A COM | 04965G109 |
| — | ATARA BIOTHERAPEUTICS INC | 400,000 | $8.044M | 0.5% | $39.75 | — | COM | 046513107 |
| QURE | UNIQURE NV | 100,000 | $7.815M | 0.4% | $63.72 | 0.0% | Call | N90064101 |
| — | KEZAR LIFE SCIENCES INC | 968,294 | $7.466M | 0.4% | $17.30 | — | COM | 49372L100 |
| GNFTY | GENFIT S A | 319,700 | $6.314M | 0.4% | $24.00 | — | ADS | 372279109 |
| — | PRECISION BIOSCIENCES, INC - SERIES B PREFERRED | 467,518 | $6.195M | 0.4% | $17.95 | — | COM | 74019P108 |
| — | HOMOLOGY MEDICINES INC | 300,000 | $5.871M | 0.3% | $19.57 | — | COM | 438083107 |
| IFRX | INFLARX NV | 1,500,000 | $4.74M | 0.3% | $27.44 | +15.3% | COM | N44821101 |
| — | AVROBIO INC | 275,000 | $4.472M | 0.3% | $28.56 | — | COM | 05455M100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 50,000 | $4.222M | 0.2% | $31.24 | +162.8% | COM | 64125C109 |
| — | MINERVA NEUROSCIENCES INC | 607,903 | $3.422M | 0.2% | $7.26 | — | COM | 603380106 |
| — | AUDENTES THERAPEUTICS INC | 75,000 | $2.84M | 0.2% | $18.38 | — | COM | 05070R104 |
| — | ITERUM THERAPEUTICS PLC | 396,385 | $2.727M | 0.2% | $10.89 | — | SHS | G6333L101 |
| SRRK | SCHOLAR ROCK HLDG CORP | 150,000 | $2.379M | 0.1% | $18.88 | -1.9% | COM | 80706P103 |
| — | ABEONA THERAPEUTICS INC | 350,000 | $1.673M | 0.1% | $8.20 | — | COM | 00289Y107 |
| — | ACCELERON PHARMA INC | 40,000 | $1.643M | 0.1% | $32.04 | — | COM | 00434H108 |
| ACRS | ACLARIS THERAPEUTICS INC | 250,000 | $548K | 0.0% | $19.94 | -72.7% | COM | 00461U105 |
| — | OUTLOOK THERAPEUTICS INC | 416,666 | $46,000 | 0.0% | $0.15 | — | *W EXP 02/18/202 | 69012T115 |
| — | OUTLOOK THERAPEUTICS INC | 15,752 | $32,000 | 0.0% | $2.03 | — | COM NEW | 69012T206 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $3,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |